Is a complete CSE/LOBE research report available?

Question

Accepted Answer

No complete published report is available for cse/LOBE (CSE/LOBE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	26.7M
Net income (ttm)	-5.6M
EPS (ttm)	-CA$0.03
Shares out	333.6M
Volume	20,000
Beta	-0.02

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 23.1M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA53946V2066
Last refreshed	2026-09-07
Market cap	CAD 26.7M
Price	CAD 0.08
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/LOBE
Website	https://www.lobesciences.com

Metric	Value
Earnings Yield	-20.83%
P/B ratio	8.33x

Metric	Value
Net Income	CAD -5.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
ROA	-63.32
Roa5y	-68.69
ROCE	-214.1
ROE	-214.2
ROIC	-91.21

Metric	Value
Cagr1y	60.05%
Cagr3y	47.35%
Cagr5y	-28.23%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth Years	0x

CSE/LOBE (CSE/LOBE)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/LOBE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/LOBE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/LOBE

Frequently asked questions

Metric	Value
Assets	CAD 5.5M
Cash	CAD 5.2M
Current Assets	CAD 5.5M
Current Liabilities	CAD 2.3M
Debt	CAD 338,401
Debt Equity	CAD 0.11
Equity	CAD 3.2M
Liabilities	CAD 2.3M
Long Term Assets	CAD 0
Long Term Liabilities	CAD 0
Net Cash	CAD 4.9M
Net Cash By Market Cap	CAD 18.24
Net Cash Growth	-11.41%
Net Debt Equity	CAD -1.52
Tangible Book Value	CAD 1.9M
Tangible Book Value Per Share	CAD 0.01
WACC	4.1

Metric	Value
Current ratio	2.38
Net Working Capital	CAD -1.7M
Quick ratio	2.24
Working Capital	CAD 3.2M

Metric	Value
1Y total return	60%
200-day SMA	0.07
3Y total return	220%
50-day SMA	0.09
50-day SMA vs 200-day SMA	50over200
5Y total return	-80.95%
All Time High	1.8
All Time High Change	-95.56%
All Time High Date	2019-06-07
All Time Low	0.01
All Time Low Change	700%
All Time Low Date	2023-11-01
ATR	0.01
Beta	-0.02
Beta1y	-0.35
Beta2y	0.06
Ch YTD	77.78
High	0.09
High52	0.18
High52 Date	2026-05-05
High52ch	-55.56%
Low	0.08
Low52	0.03
Low52 Date	2025-12-03
Low52ch	166.67%
Ma50ch	-9.5%
Price vs 200-day SMA	7.1%
RSI	48.19
RSI Monthly	52.37
RSI Weekly	48.5
Sharpe ratio	1.47x
Sharpe Ratio3y	1.16x
Sharpe Ratio5y	0.94x
Sortino ratio	2.62
Sortino Ratio3y	2.08
Sortino Ratio5y	1.68
Total Return	-44.48%
Tr YTD	77.78
Tr1m	6.67%
Tr1w	-11.11%
Tr3m	-11.11%

Metric	Value
Float	134,384,875%
Net Borrowing	-11,373
Shares Insiders	15.76%
Shares Out	333,593,922
Shares Qo Q	3.07%
Shares Yo Y	44.48%

Metric	Value
Adjusted OCF	-4,586,180
Average Volume	104,050.5x
Bv Per Share	0.01
Ch1m	6.67
Ch1w	-11.11
Ch1y	60
Ch3m	-11.11
Ch3y	220
Ch5y	-80.95
Ch6m	45.46
Change	-5.88%
Change From Open	-5.88
Close	0.09
Days Gap	0
Dollar Volume	1,600
Earnings Date	2026-12-30
EBIT	CAD -6.9M
EPS	CAD -0.03
F Score	1
Financing CF	1,005,685
Fiscal Year End	August
Founded	2,018
Investing CF	-3,701,857
Is Primary Listing	1
Last Earnings Date	2026-01-28
Last Report Date	2026-05-31
Last Split Date	2022-06-10
Last Split Type	Reverse
Ma150	0.08
Ma150ch	-5.21%
Ma20	0.08
Ma20ch	1.52%
Net CF	-6,463,004
Next Earnings Date	2026-12-30
Open	0.09
Position In Range	0
Price Date	2026-09-03
Ptbv Ratio	14.15
Relative Volume	0.19x
Share Based Comp	842,240
Tr6m	45.46%
Volume	20,000